Center Laboratories, Inc. (TPEX:4123)
Taiwan · Delayed Price · Currency is TWD 40.00
+0.30 (0.76%)
Feb 11, 2026, 1:30 PM CST
Center Laboratories Revenue
Center Laboratories had revenue of 359.11M TWD in the quarter ending September 30, 2025, a decrease of -8.50%. This brings the company's revenue in the last twelve months to 1.57B, down -0.61% year-over-year. In the year 2024, Center Laboratories had annual revenue of 1.62B with 16.06% growth.
Revenue (ttm)
1.57B
Revenue Growth
-0.61%
P/S Ratio
19.08
Revenue / Employee
n/a
Employees
n/a
Market Cap
29.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.62B | 223.86M | 16.06% |
| Dec 31, 2023 | 1.39B | 626.29M | 81.58% |
| Dec 31, 2022 | 767.72M | 267.62M | 53.51% |
| Dec 31, 2021 | 500.11M | -216.94M | -30.25% |
| Dec 31, 2020 | 717.05M | -720.63M | -50.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| Grape King Bio | 10.40B |
| YungShin Global Holding | 8.37B |
| Standard Chemical & Pharmaceutical | 6.91B |
| TTY Biopharm Company | 6.50B |
| Synmosa Biopharma | 6.11B |
| ScinoPharm Taiwan | 3.19B |